Nombre del producto:Isoquinoline, 4-(3-bromophenyl)-6,8-dichloro-1,2,3,4-tetrahydro-2-methyl-, (4S)-

IUPAC Name:(4S)-4-(3-bromophenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline

CAS:1870821-29-6
Fórmula molecular:C16H14BrCl2N
Pureza:95%+
Número de catálogo:CM429816
Peso molecular:371.1

Unidad de embalaje Stock disponible Precio($) Cantidad
CM429816-100mg in stock ǜƎƦ
CM429816-250mg in stock ƎȺȬ
CM429816-1g in stock ƦǜƦ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :1870821-29-6
Fórmula molecular:C16H14BrCl2N
Punto de fusión:-
Código de sonrisas:CN1C[C@@H](C2=CC(Br)=CC=C2)C2=C(C1)C(Cl)=CC(Cl)=C2
Densidad:
Número de catálogo:CM429816
Peso molecular:371.1
Punto de ebullición:
Nº Mdl:MFCD27939616
Almacenamiento:

Category Infos

Tetrahydroisoquinolines
Tetrahydroisoquinoline is an organic compound with the chemical formula C9H11N. It is classified as a secondary amine, obtained from isoquinoline by hydrogenation. The tetrahydroisoquinoline moiety forms the backbone of several natural, synthetic and semi-synthetic drugs approved for the treatment of cancer, pain, gout and various neurodegenerative diseases.

Column Infos

Tenapanor
FDA has approved XPHOZAH (tenapanor), the first and only phosphate absorption inhibitor, indicated to reduce serum phosphorus in adults with chronic kidney disease (CKD) on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

XPHOZAH, with its unique blocking mechanism of action, acts locally in the gut to inhibit the sodium hydrogen exchanger 3 (NHE3), reducing phosphate absorption through the paracellular pathway, the primary pathway of phosphate absorption.